⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of K.C. Pharmaceuticals, Inc. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
K.C. Pharmaceuticals, Inc.
↗Pomona, USA
K.C. Pharmaceuticals is a prominent private label and contract manufacturer specializing in ophthalmic (eye care) and lens care products in North America. The company provides manufacturing services to a significant portion of the top U.S. retailers, focusing on over-the-counter (OTC) medications and medical devices.
The company operates out of a campus in Pomona, California, with approximately 150,000 square feet of manufacturing space. They emphasize adherence to Current Good Manufacturing Practices (CGMP) and maintain extensive distribution capabilities across the United States.
CLASSIFICATION
Company Type:CDMO
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Ophthalmic/OTC Contract Manufacturing
SIZE & FINANCIALS
Employees:51-200
Revenue:$50M-$100M
Founded:1988
Ownership:private
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Major US Retailers (Food/Drug/Mass chains)
COMPETITION
Position:Niche Player
Competitors:Similasan Corporation, Xlear, Inc., Cosette Pharmaceuticals, Curia Global
LEADERSHIP
Key Executives:
Ratna Li - CEO
LINKS
Website:kc-ph.com
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with K.C. Pharmaceuticals, Inc.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.